[Form 4] Nicholas Financial Inc Insider Trading Activity
Charles Krebs, identified as Chief Financial Officer of Old Market Capital Corp (OMCC), reported two purchases of common stock on this Form 4. On 09/09/2025 he purchased 84 shares at a weighted-average price of $5.42, bringing his beneficial ownership to 11,883 shares. On 09/10/2025 he purchased 591 shares at a weighted-average price of $5.41, increasing his total to 12,474 shares. The filing notes the 09/09 and 09/10 purchases were executed in multiple transactions with price ranges of $5.35–$5.42 and $5.39–$5.45 respectively. The form is signed by Charles Krebs on 09/11/2025.
- Insider purchase disclosed: CFO Charles Krebs increased his beneficial ownership, adding 675 shares over two days.
- Transparent pricing detail: Filing provides weighted-average prices and commits to supply per-trade breakdowns on request.
- None.
Insights
TL;DR: Insider purchases small incremental shares over two days, modestly increasing CFO ownership.
The reported transactions show the Chief Financial Officer acquired a total of 675 common shares across two trading days at roughly $5.41–$5.42 per share, lifting his position from 11,208 to 12,474 shares. The purchases were executed via multiple trades at slightly varying prices, as disclosed. From an investor perspective, modest insider purchases can signal personal confidence, but the absolute size appears small relative to typical market-cap positions and lacks context on overall share count. No derivative transactions or dispositions are reported.
TL;DR: CFO reported timely Section 16 purchases with full explanatory pricing ranges; disclosure practices appear compliant.
The Form 4 includes required explanatory language about weighted-average prices and commits to provide breakdowns on request, which aligns with good disclosure practice. The filing is signed and dated within a reasonable window after the transactions. There is no indication of sales, option exercises, or transactions under a Rule 10b5-1 plan disclosed on this form. For governance review, these are routine insider purchases without apparent compliance red flags in the filing itself.